Author:
Fricke Uwe,Schwabe Ulrich
Publisher
Springer Berlin Heidelberg
Reference137 articles.
1. Aragon-Ching JB, Li H, Gardner ER, Figg WD (2007): Thalidomide analogues as anticancer drugs. Recent Patents Anticancer Drug Discov 2: 167–174.
2. Arzneimittelkommission der deutschen Ärzteschaft (2004): Empfehlungen zur Therapie der peripheren arteriellen Verschlusskrankheit (pAVK). 3. Auflage. Arzneiverordnung in der Praxis, Band 31 Sonderheft 3. Im Internet unter: www.akdae.de/35/72_pAVK_2004_3Auflage.pdf
3. Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE; Sitagliptin Study 021 Group (2006): Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 29: 2632–2637.
4. Aubin HJ, Bobak A, Britton JR, Oncken C, Billing CB Jr, Gong J, Williams KE, Reeves KR (2008): Varenicline versus transdermal nicotine patch for smoking cessation: Results from a randomised, open-label trial. Thorax. 2008 Feb 8; [Epub ahead of print]
5. Benedict NJ (2007): Sitaxsentan in the management of pulmonary arterial hypertension. Am J Health Syst Pharm 64: 363–368.